On April 10, 2026, CMS released one of the most consequential prior authorization rules in years: the 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P). While the 2024 final rule addressed non-drug items and services, this new proposal extends electronic prior authorization mandates to prescription drugs — a category that accounts for an outsized share of administrative burden in specialty practices.
Medicare Advantage plans made 52.8 million prior authorization determinations in 2024, denying 4.1 million requests — a 7.7% denial rate. But when appeals were filed, 80.7% were overturned, suggesting systematic over-denial. This rule forces payers to speed up decisions and disclose their track records publicly.
The comment period runs through June 15, 2026. Practices that submit comments — especially those documenting patient care delays from slow drug PAs — help shape the final rule. MGMA, AAPC, and AMA are coordinating comment campaigns.
Two conflicting signals define the payer landscape this week. On the positive side, UnitedHealthcare announced May 5, 2026 that it will eliminate an additional 30% of remaining prior authorizations by year-end — including select outpatient surgeries, echocardiograms, certain outpatient therapies, and chiropractic care. UHC claims 92% of submitted authorizations are now approved in under 24 hours and PA is required for only 2% of covered medical services.
But the broader picture remains grim. A May 2026 HealthLeaders survey reveals that 78% of revenue cycle leaders attribute at least 10% of their delayed payments to payer-related causes.
| Payer | PA Volume Standardized | Key Action |
|---|---|---|
| UnitedHealthcare | 70%+ ePA by year-end | Cutting 30% more PAs; 1,500 rural hospitals exempt |
| Aetna | 88% standardized | Bundling medical + drug PA into single request |
| Cigna | 70%+ by year-end | Eliminated PA for ~100 services; CoverMyMeds as ePA platform |
| Humana / Elevance / BCBS | Pledged standardization | Honoring PAs for 90 days during plan transitions |
On May 4, 2026, Carlyle Group acquired a majority stake in Knack RCM and EqualizeRCM, while 60% of revenue cycle leaders plan to change vendor strategies within two years — with 75% of that group expanding outsourcing.
The OIG confirmed that MA plans overturned ~75% of their own PA denials on appeal — proving systematic first-pass over-denial. If your practice isn’t appealing every clinical denial, you’re leaving money on the table. Build an appeal-everything policy.
Oliver Wyman’s landmark May 2026 Healthcare RCM Survey — covering 200+ decision-makers and 90 end users — paints a picture of an industry at an inflection point: AI adoption is accelerating, but realistic ROI expectations are replacing early hype.
| Metric | Value |
|---|---|
| Organizations with AI integrated in RCM | 63% |
| Health systems exploring/piloting/deploying GenAI for RCM | 80% (up 38 pts in 2 years) |
| Broad or enterprise-wide AI deployment | 20–40% |
| Decision-makers planning to increase AI spending (next 3 years) | 70–90% |
| Leaders seeing “no-regret” AI investments in RCM | 92% |
Denial rates above 10% have surged from 30% of providers in 2022 to 41% in 2025, driven in part by payers deploying AI to review and deny claims faster. The provider response is counter-AI: AI-enabled pricing engines that automatically identify underpayments, and generative AI appeal writers that draft clinically-supported appeals in seconds.
The Oliver Wyman data confirms that ambient documentation, CDI, and ePA are the three “no-regret” AI investments. If your practice hasn’t piloted at least one of these by Q3 2026, you’re falling behind 63% of the market.
CMS released its April 2026 ICD-10-CM update, adding new diagnosis codes mid-cycle — a pattern that’s becoming the norm as CMS responds to clinical realities faster than the annual October cycle allows.
| Code Set | New | Deleted | Revised |
|---|---|---|---|
| CPT 2026 | 288 | 84 | 46 |
| ICD-10-CM (Oct 2025 cycle) | 614 | 28 | 38 |
| ICD-10-CM (April 2026 mid-year) | Additional codes | — | — |
AI-driven payer audits are increasingly flagging unspecified ICD-10 codes. The April 2026 mid-year update gives practices the tools to code with the specificity that keeps claims clean. Update your code sets immediately.
The performance gap in revenue cycle is widening. While MGMA benchmarks show the industry average for Days in A/R remains above 40 days, top-performing practices have pushed below 25 days — creating a 15+ day cash flow advantage that compounds across the year.
| KPI | Industry Average | Target | Top Performer |
|---|---|---|---|
| Days in A/R | 40+ days | < 30 days | < 25 days |
| Clean Claims Rate | 90–93% | > 95% | > 98% |
| Net Collection Rate | 92–94% | > 95% | 97–99% |
| Denial Rate | 8–12% | < 5% | < 3% |
| Cost to Collect | 5–7% | < 4% | < 3% |
A practice billing $5M annually that moves from 40 to 25 days in A/R unlocks approximately $205,000 in accelerated cash flow — money that’s sitting in the pipeline instead of earning interest or funding operations.
Calculate your practice’s Days in A/R this week. If you’re above 35 days, prioritize front-end eligibility automation and same-day claim submission. Every day you shave off A/R is money in the bank.
The RCM technology landscape is consolidating around AI-native platforms. This week’s key developments:
CodaMetrix’s AI coding platform is now reporting verified outcomes: 70% reduction in manual coding labor and a 59% drop in coding-related denials. The platform earned KLAS category leadership in Autonomous Coding — a new category that didn’t exist two years ago.
| Category | Winner | Score |
|---|---|---|
| End-to-End RCM Outsourcing | Ensemble Health Partners | 95.1/100 |
| Claims Management | Waystar | 91.8/100 |
| Contract Management | Experian Health | 90.3/100 |
| Ambulatory RCM | ARIA RCM | Best in KLAS |
| Patient Engagement | RevSpring | 90.3/100 |
| Autonomous Coding | CodaMetrix | Category Leader |
Waystar previewed four new capabilities at its innovation event: AI-powered underpayment detection, predictive denial prevention, automated patient financial engagement, and real-time claims intelligence. The Waystar True North Client Conference is scheduled for August 25–27 in San Antonio, TX.
The vendor landscape is bifurcating: AI-native platforms vs. legacy systems bolting on AI. Practices evaluating RCM technology should prioritize vendors with demonstrated autonomous coding accuracy and measurable denial reduction — not just AI marketing.
CMS began enforcing updated Hospital Price Transparency requirements on April 1, 2026, following the CY 2026 OPPS/ASC final rule. The new requirements include:
On April 2, 2026, CMS and the Departments of Labor, Treasury, and OPM released a joint FAQ extending enforcement discretion for health plans calculating qualifying payment amounts (QPAs) using the 2021 methodology. Plans using legacy QPA calculations will not face enforcement action — yet.
| State | Key Provision |
|---|---|
| Virginia | PA approvals valid minimum 6 months; renewals minimum 12 months |
| Washington | Bans AI as sole basis for denials; requires transparency on AI use |
| Alaska | 72-hour routine / 24-hour expedited PA decision windows |
| North Dakota | Faster PA response times mandated |
| Nebraska | Accelerated PA response time requirements |
Washington State’s AI denial ban is the leading edge of a national trend. Practices in states without similar protections should document every instance of an apparent AI-generated denial (look for generic denial language, no clinical rationale) — this data supports both appeals and future state legislation.
The share of physicians in private practice fell to 42.2% in 2024 (down from 60.1% in 2012), with 34.5% now in hospital-owned settings and 6.5% under private equity ownership. Yet consolidation activity has slowed — PE deal volume has “quieted down” after a post-COVID spike — suggesting independent practices that survive the current squeeze may find more room to operate.
| Strategy | % of Practices |
|---|---|
| Automation | 36% |
| Process improvement | 23% |
| Hiring freezes / cuts | 18% |
| Outsourcing | 14% |
| New vendors | 9% |
| Benchmark | Where Most Are | Where You Should Be |
|---|---|---|
| Days in A/R | 38–45 days | < 32 days |
| Net Collection Rate | 91–93% | > 96% |
| Denial Rate | 8–12% | < 5% |
| Cost to Collect | 6–8% | < 4.5% |
| Clean Claims Rate | 88–92% | > 95% |
| Front-end eligibility automation | Manual or partial | Real-time, at scheduling |
| AI coding assistance | None | At least pilot-stage |
If you’re an independent practice with a net collection rate below 95%, the single highest-ROI investment is real-time eligibility verification at scheduling combined with automated claim scrubbing. These two automations alone can shift 3–5 percentage points on NCR within 90 days.
| Specialty | Key Update | Impact |
|---|---|---|
| Primary Care | CMS expanded reimbursement for CCM, PCM, TCM, and RPM — now valued at $280–$420 per eligible patient annually. New RPM codes lower the time threshold from 20 to 10 minutes. | Bill every eligible chronic care patient. The ROI on CCM enrollment has never been higher. |
| Cardiology | Overall cardiovascular reimbursement up ~1% for 2026. Facility-based cardiology services down 7%. New mandatory Ambulatory Specialty Model (ASM) for heart failure launching 2027. | Office-based cardiology benefits; hospital-based faces compression. Begin ASM readiness planning now. |
| Orthopedics | The 2.5% efficiency adjustment hits surgical procedures, diagnostic imaging, and outpatient interventions hardest. CMS PA reform cuts payer decision windows from 14 to 7 days. | Model the wRVU impact on your top 20 procedures. Faster PA turnaround partially offsets the payment cut. |
| Oncology | Drug PA reform (CMS-0062-P) mandates 24-hour urgent / 72-hour standard decision windows for drug PAs — directly targeting chemotherapy and immunotherapy delays. | Submit comments by June 15 documenting care delays from slow drug PAs. |
| Mental Health | New ICD-10-CM codes for opioid use disorder specificity. Behavioral health parity enforcement increasing. CMS PA reform highlights behavioral health as a priority area. | Update opioid-related code sets. File complaints when payers apply different PA standards to mental health. |
| Radiology | Comprehensive CPT overhaul for lower extremity revascularization and vascular/interventional imaging codes. The −2.5% efficiency adjustment applies to diagnostic imaging. | Complete code crosswalk for revised radiology CPT codes before the next billing cycle. Train coders on the new interventional radiology structure. |
The 2026 PFS rewards office-based cognitive services and penalizes facility-based procedural work. Practices with the flexibility to shift appropriate services to the office setting will see net payment gains.